Hematopoietic cell transplant therapy specialist Jasper Therapeutics (Nasdaq:JSPR) has made several changes to its management team. The Redwood City, California–based company has promoted Jeet Mahal to chief operating officer. Mahal previously served as the company’s chief financial and business officer. Jasper has also elevated Dr. Wendy Pang to be the company’s senior vice president of…
Humacyte to go public via SPAC
The biotech platform company Humacyte is merging with Alpha Healthcare Acquisition Corp. (NSDQ:AHAC) (“AHAC”), a special purpose acquisition company (SPAC). AHAC’s shareholders approved the deal today and plan to submit results from the meeting to the SEC via a Form 8-K document. The two organizations expect the merger to finalize on August 26 and stock…